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MAIN TEXT
Most monogenic cases of obesity in humans have been linked to mutations in genes of the 
leptin-melanocortin pathway. Specifically, mutations in the Melanocortin-4 Receptor 
(MC4R), account for 3–5% of all severe obesity cases in humans1–3. Recently, adenylate 
cyclase 3 (ADCY3) mutations have been implicated in obesity4,5. ADCY3 is expressed at 
the primary cilia of neurons6, organelles that function as hubs for select signaling pathways. 
Mutations that disrupt the functions of primary cilia cause ciliopathies, rare recessive 
pleiotropic diseases, of which obesity is a cardinal manifestation7. We demonstrate that 
MC4R co-localizes with ADCY3 at the primary cilium of a subset of hypothalamic neurons, 
that obesity-associated MC4R mutations can impair ciliary localization and that inhibition of 
adenylyl-cyclase signaling at the primary cilia of these neurons increases body weight. 
These data point at impaired signaling from the primary cilia of MC4R neurons as a 
common pathway for genetic causes of obesity in humans.
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The majority of mammalian cells, including neurons, possess a single, immotile primary 
cilium, an organelle that transduces select signals7,8. Defects in the genesis or function of 
primary cilia cause a range of overlapping human diseases, collectively termed 
ciliopathies7,9,10. Several ciliopathies, such as Bardet-Biedl syndrome and Alström 
syndrome, cause obesity11, and mutations in genes encoding ciliary proteins, such as CEP19 
and ANKRD26, cause non-syndromic obesity in mice and humans12,13. While the 
mechanisms underlying a number of ciliopathy-associated phenotypes, such as polycystic 
kidney disease or retinal degeneration, have been at least partly elucidated, how ciliary 
dysfunction leads to obesity remains poorly understood7,11. Ubiquitous ablation of the 
primary cilia of neurons in adult mice causes an increase in food intake and obesity, 
suggesting that ciliopathy-associated obesity involves the post-developmental disruption of 
anorexigenic neuronal signals14. Recently, genetic and epigenetic studies have suggested a 
role for ADCY3 variations in human obesity4,15 and loss of function mutations in Adcy3 in 
mice leads to a severe obesity phenotype5. ADCY3, a member of the adenylyl cyclase 
family that mediate Gs signaling from G-Protein Coupled Receptors (GPCRs), is 
specifically expressed at the primary cilia of neurons6.
The melanocortin 4 Receptor (MC4R) is a Gs-coupled GPCR that transduces anorexigenic 
signals in the long-term regulation of energy homeostasis16. Heterozygous mutations in 
MC4R are the most common monogenic cause of severe obesity in humans and individuals 
with homozygous null mutations display severe, early-onset obesity1–3. Similar to humans, 
deletion of Mc4r in mice causes severe obesity17. MC4R is a central component of the 
melanocortin system, a hypothalamic network of neurons that integrates information about 
peripheral energy stores and that regulates food intake and energy expenditure18. Despite 
being a major target for the pharmacotherapy of obesity, nothing is known about the sub-
cellular localization of MC4R.
When expressed in un-ciliated heterologous cells, MC4R traffics to the cell membrane2. 
However, in ciliated cells such as mouse embryonic fibroblasts (MEFs), Retinal Pigment 
Epithelium (RPE), Inner Medullary Collecting Duct (IMCD3) cells, we find that a 
previously well-characterized, functional, C-terminally GFP-tagged MC4R (MC4R-GFP)19 
localizes to primary cilia (Fig. 1A). In a quantitative assay, developed in IMCD3 cells, the 
ciliary enrichment of MC4R was comparable to that of Smoothened (SMO), a known 
cilium-enriched protein20,21 and was the strongest among members of the melanocortin 
receptor family (Fig. 1 B).
We set out to determine if, and to what extent, MC4R localizes to primary cilia in vivo in 
mice. Most of the anorexigenic activity of MC4R is due to its function in a subset of Single 
Minded 1 (SIM1)-expressing neurons of the paraventricular nucleus of the hypothalamus 
(PVN)22 and all MC4R expressing neurons in the PVN express SIM123. Using a transgenic 
mouse line in which GFP is expressed in all SIM1-expressing neurons, we first investigated 
whether SIM1 expressing PVN neurons are ciliated. We find that an Adenylate-Cyclase 3 
(ADCY3)-positive primary cilium was found at a majority of SIM1-expressing neurons of 
the PVN (Supplementary Fig. 1).
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Previous attempts to determine the subcellular localization of MC4R in vivo in mice have 
been unsuccessful due to the small number of neurons in which it is expressed, its low 
abundance and the lack of tractable antibodies. Using Cas9-mediated recombination in 
mouse zygotes, we inserted a GFP tag in frame at the C-terminus of the endogenous mouse 
Mc4r locus (Fig. 2A). MC4R-GFP/+ knock-in mice do not have an obvious energy 
metabolism phenotype and are fertile, suggesting that the C-terminal GFP does not 
significantly impair the trafficking or function of MC4R in these mice. Confocal imaging of 
the PVN of these mice demonstrates that MC4R co-localizes with ADCY3 to the primary 
cilia of a subset of PVN neurons in vivo (Fig. 2, B–I).
If MC4R localization to the primary cilia is essential for its function, then human obesity-
causing mutations in MC4R may impair its function by compromising its ciliary 
localization. Heterozygous MC4R mutations are the most common genetic cause of severe 
childhood obesity1. Over fifty different obesity-associated mutations in MC4R have been 
described24 (Supplementary Fig. 2). Functional assessment of the effects of these mutations 
in non-ciliated cells has revealed that many of these mutations disrupt trafficking of the 
receptor to the membrane or impair ligand activation (Supplementary Fig. 2). In non-ciliated 
HEK293 cells, eight obesity-associated MC4R mutant proteins (p.(Arg7His), p.(Thr150Ile), 
p.(Pro230Leu), p.(Gly231Ser), p.(Arg236Cys), p.(Leu250Gln), p.(Gly252Ser), p.
(Ile130Thr) ) traffic normally to the cell membrane and respond normally to α-MSH 
activation2,24–27. To determine whether any of these mutations alter ciliary localization of 
MC4R, we quantified their ciliary enrichment in IMCD3 cells (Fig. 3A). We found that 
P230L and R236C significantly decreased MC4R ciliary localization. Interestingly, these 
two mutations are located in the third intracellular domain of MC4R (Supplementary Fig. 2), 
a domain previously implicated in ciliary localization of other GPCRs28.
To further determine whether the P230L mutation alters ciliary localization in vivo, we 
injected AAVs that express MC4R-P230L-GFP and MC4R-GFP in a Cre-dependent fashion 
into Sim1-Cre transgenic mice (Fig. 3 B–D). The human wild-type MC4R-GFP localized to 
primary cilia of Sim1-expressing PVN neurons (Fig. 3 E–H) confirming that the human 
receptor also traffics to the cilia in vivo. In contrast, MC4R-P230L-GFP failed to co-localize 
with ADCY3 to primary cilia (Fig. 3 I–L). Together, these results suggest that MC4R 
mutations may cause human obesity by altering the ciliary localization of the receptor.
If MC4R and ADCY3 function at the primary cilia to regulate body weight, we predicted 
that specific inhibition of Adenylyl cyclase at the primary cilia of MC4R expressing neurons 
should be sufficient to cause obesity. Specific inhibition of Adenylyl cyclase at primary cilia 
of neuron can be achieved by expression of a constitutively active version of the cilia 
specific Gi-protein coupled receptor GPR88 (GPR88p.(Gly283His) or GPR88*)29. GPR88* 
was delivered to Sim1 expressing neurons of the PVN using the same approach used for the 
hMC4RGFP DIO-AAV (Fig 3) but using high level of virus delivered at the midline to 
ensure large coverage of PVN neurons (Supplementary Figure 3). As visualization of cilia 
expression requires confocal imaging, a DIO-AAV expressing mCherry was co-injected with 
the DIO-AAV expressing a Flag tagged version of GPR88* to facilitate verification of the 
accuracy of the targeting and the coverage of the PVN at the end of the experiment in each 
mouse (Supplementary Fig. 3). Weight-paired littermate mice injected only with the 
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mCherry DIO-AAV were used as controls. Following AAV injections, mice in which Flag-
GPR88* was expressed at the primary cilia of Sim1 expressing PVN neurons increased their 
food intake and gained significant weight compared to controls (Figure 4) demonstrating 
that Adenylyl cyclase signaling at the primary cilia of these neurons is essential for the 
regulation of body weight.
Combined, our data suggest that impaired signaling from the primary cilia of MC4R 
expressing neurons is a common pathway for syndromic and non-syndromic causes of 
monogenic obesity in humans. Our data do not indicate, however, that the primary cilia is 
necessary for Gs coupling and ADCY activation by MC4R since these occur in non ciliated 
cells. Rather our data suggest that this signaling has to occur at the primary cilia since 
impairing localization of MC4R at the primary cilia or inhibiting ADCY at the primary cilia 
impairs regulation of body weight. This functional link between MC4R and ciliopathy-
associated obesity parallels findings underlying other human ciliopathy associated 
phenotypes. For example, syndromic and non-syndromic polycystic kidney disease is linked 
to impaired function of Polycytin 1 and 2, proteins expressed at the primary cilia of renal 
tubular cells, while impaired function of Rhodopsin (RHO) in the anterior segment of retinal 
cells, a specialized primary cilia, is a common pathway for both common and ciliopathy 
associated retinal phenotypes7.
Our findings also provide important new insights into the sub-cellular basis underlying the 
relationship between short-term regulation of food intake and long-term regulation of energy 
homeostasis. PVN MC4R expressing neurons are part of a neuronal circuitry implicated in 
short term control of feeding as they receive synaptic gabaergic and glutamatergic inputs in 
particular from the arcuate nucleus of the hypothalamus30. MC4R itself, however, controls 
long-term energy homeostasis as evidenced by the phenotype of MC4R deficient mice or 
humans and both MC4R ligands have a slower effect on food intake regulation. In strong 
support of this model, a recent report has elegantly established that the PVN MC4R 
expressing neurons receive fast-acting food intake regulating synaptic inputs from the ARC 
that are post-synaptically modulated by MC4R through its slower acting neuropeptide 
ligands αMSH and AGRP30.
Our finding that MC4R localizes to the primary cilia of MC4R PVN neurons provides for a 
sub-cellular compartmentalization of the slower signaling by the endogenous MC4R ligands, 
allowing for an independent control of long-term energy homeostasis, in neurons also 
implicated in the short-term regulation of food intake.
ONLINE METHODS
Studies in cell lines
Expression plasmids—hMC1R-GFP, hMC2R-GFP, hMC3R-GFP and hMC5R-GFP 
expression constructs were constructed as previously described for hMC4R-GFP18, as have 
the hMC4R mutant constructs used25.
Ciliary expression of MC4R in cultured cells—Cell lines [IMCD3 (ATCC 
CRL2123), MEF (NIH/3T3 ATCC CRL-1658) and RPE (ATCC CRL-4000)] were 
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maintained at 37°C and 5% CO2 and cultured in 50% DMEM/50% Ham’s F-12 nutrient mix 
(CCF, UCSF, San Francisco, CA), 10% FBS, and 2mM Glutamax (GIBCO, CA) (IMCD3) 
or DMEM (CCF) with 10% FBS (MEF). Effectene (QIAGEN, Chatsworth, CA) was used 
for transfections according to the manufacturer’s protocol. Upon reaching confluency, cells 
were cultured in Opti-MEM (Life Technologies) for 24h to induce ciliation. Plasmid-
transfected cells were fixed and stained prior to imaging by confocal microscopy. For 
immunofluorescence staining, cells were fixed with 4% PFA for 20 min at 4°C, 
permeabilized in binding buffer (10% BSA, 2% goat serum and 0.02% NaAzide in PBS) 
with 0.3% Triton-X100 (Sigma), and blocked in binding buffer with 3% goat serum. Primary 
antibodies were added in binding buffer and incubated overnight at 4°C. Subsequently, cells 
were washed in PBS followed by a 1h incubation with secondary antibodies and 5 min 
incubation with Hoechst33342 at room temperature and mounted in Prolong Gold (Life 
Technologies). GFP was detected by chicken polyclonal anti-GFP (abcam, ab13970). The 
Flag epitope was detected by mouse monoclonal anti-FlagM2 (Sigma, F1804). Primary cilia 
were detected by mouse monoclonal anti-Acetylated tubulin (Sigma, T7451), rabbit anti-
Arl13b (gift of Tamara Caspary), or rabbit anti-Adcy3 (Santa Cruz Biotechnology, sc-588). 
Secondary antibody: goat anti-chicken Alexa fluor 488 (Invitrogen, A11039), goat anti-
mouse Alexa fluor 555 (Invitrogen, A21424), goat anti-rabbit Alexa fluor 555 (Invitrogen, 
A21429), or goat anti-mouse Alexa fluor 633 (Invitrogen, A21052). Nuclei were labeled by 
DAPI, To-Pro3 (Invitrogen) or Hoechst33342 (Invitrogen).
Microscopes—Imaging of transfected immortalized cells was performed on a Zeiss 
Upright Axioscope 2 Plus Fluorescence Microscope and/or on a Leica SL, a Leica SP5 or a 
Zeiss LSM 780 confocal microscope.
Quantification of ciliary localization in cultured cells—A 3-plane Z-stack of 
transiently transfected IMCD3 cells was acquired on an Olympus IX-70 microscope, and 
best focus of average was recorded using Metamorph software (Molecular Devices, 
Sunnyvale, CA). Relative ciliary enrichment was calculated using Matlab Software as the 
ratio between the green chanel pixel intensity of GFP-chimera expression at the primary 
cilium versus pixel intensity of the cell body, wherein the cilium was defined by acetylated 
tubulin staining recorded in the red channel.
In vivo studies in mice
All animal procedures were approved by the Institutional Animal Care and Use Committee 
of the University of California, San Francisco. Zygote injection and implantation was 
performed at the transgenic core of the Gladstone Institute.
Generation of Mc4r-GFP knock-in mice—Super-ovulated female FVB/N mice (4 
weeks old) were mated to FVB/N stud males. Fertilized zygotes were collected from 
oviducts and injected with (1) Cas9 protein (50 ng/ul), (2) a donor vector (20 ng/ul) 
consisting of 1kb of 5’flanking sequence (i.e. the MC4R coding sequence) followed by GFP 
(cloned in frame) and 5.5 kb of 3’flanking sequence and (3) a sgRNA (25 ng/ul) of which 
the guide sequence (see supplementary table) was designed to target nucleotides 
immediately downstream the MC4R stop codon in a short region that was not present in the 
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donor vector into pronucleus. Injected zygotes were implanted into oviducts of 
pseudopregnant CD1 female mice. Pups were genotyped for insertions at the correct loci by 
PCR. Tissue specific expression of Mc4r-GFP was verified by qPCR. Imaging experiments 
were done in F2–F5 mice from two different founders.
Origin of the other mouse lines used—Mice expressing Cre under the control of the 
Sim1 promoter, Tg(Sim1-cre)1Lowl, were obtained from Jackson Laboratories (Bar Harbor, 
ME). Sim1-GFP mice, Tg(Sim1-EGFP)AX55Gsat, were obtained from the Mutant Mouse 
Regional Resource Center (Davis, CA).
Mice were housed in a barrier facility and maintained on a 12:12 light cycle (on: 0700-1900) 
at an ambient temperature of 23±2°C and relative humidity 50–70%. Mice were fed with 
rodent diet 5058 (Lab Diet) and group-housed up to 5. Experiments were performed with 
weight matched littermates.
Generation and injection of AAVs—AAV DIO MC4RGFP, AAV DIO 
P230LMC4RGFP and AAV DIO GPR88* plasmids were generated by replacing 
hChR2(H134R)-EYFP in pAAV-Ef1a-DIO- hChR2(H134R)-EYFP-WPRE-pA (obtained 
from K. Desseiroth, Stanford University) with hMC4RGFP, P230LMC4RGFP or 
GPR88(G283H) respectively. AAV DJ were prepared and titrated by the Stanford 
Neuroscience Viral Core which also provided the stock mCherry DIO-AAV ( GVVC-
AAV-14).
DIO AAV were injected in the PVN of Tg(Sim1-cre)1Lowl mice to anatomically and 
genetically restrict expression to Sim1 expressing PVN neurons. For experiments presented 
in Figure 3, 0.2 ul of AAV DIO MC4RGFP or AAV DIO P230LMC4RGFP were 
stereotaxically injected unilaterally in the PVN (coordinates: AP=−0.8, ML=0.2, DV=−5.2). 
Mice were sacrificed 7 days after the injections. For experiments presented in Figure 4 (and 
supplementary Figure 3), AAV DIO mCherry +/− AAV DIO Flag-GPR88* were 
stereotaxically injected in 1ul at the midline just above the third ventricle (coordinates: AP=
−0.8, ML=0.0, DV=−5.2). Weight was measured for 2 months, after which mice were 
sacrificed to confirm the site of injection. Mice with missed injections were excluded prior 
to data analysis. mCherry expression was assessed in all mice by widefield microscopy to 
verify the accuracy and extent of the AAV infection and GPR88* expression since in mice 
injected with both AAV DIO mCherry and AAV DIO Flag-GPR88* infected neurons were 
infected with both viruses (supplementary figure 3).
Mouse Metabolism Studies—For experiments presented in Figure 4 (and 
supplementary Figure 3), mice were single housed after AAV injections. Weight was 
measured for 2 months. Food intake was measured by CLAMS (Columbus Instruments, 
Columbus, OH) at baseline and 6 weeks after AAV injections. Mice were tested over 96 
continuous hours, and the data from the middle 48 hours were analyzed.
Immunofluorescence studies of mouse hypothalamus—Mice were perfused trans-
cardially with PBS followed by 4% paraformaldehyde fixation solution. Brains were 
dissected and post-fixed in fixation solution at 4°C overnight, soaked in 30% sucrose 
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solution overnight, embedded in O.C.T. (Tissue-Tek, Sakura Finetek USA, INC., Torrance, 
CA), frozen, and cut into 20–35 μm coronal sections. After washing, sections were blocked 
for 1 hr (3% normal goat serum in PBS, 0.4% Triton X-100, 0.2% sodium azide) followed 
by incubation with primary antibody: chicken anti GFP (abcam, ab13970), rabbit anti-Adcy3 
(Santa Cruz Biotechnology, sc-588) or mouse anti FLAG M1 (Sigma, F3040) overnight at 
4°C. Sections were extensively washed in PBS, and then incubated with secondary antibody: 
goat anti-chicken Alexa fluor 488 (Invitrogen, A11039), goat anti-mouse Alexa fluor 488 
(Invitrogen, A11001), or goat anti-rabbit Alexa fluor 633 (Invitrogen, A21071).
Image capture and processing—Widefield images were generated using a Zeiss 
ApoTome microscope. Confocal images were generated using a Zeiss LSM 780 confocal 
microscope. In confocal images, MC4R-GFP was labeled with Alexa 488, and the neuronal 
cilia marker Adcy3 was labeled with Alexa 633. For Alexa 488, the detector range was set 
from 490–534 nm. For Alexa 633, the detector range was set from 600–750 nm. Images 
were processed with Fiji. Maximal intensity Z projections are from at least 20 slices over 10 
μm.
In confocal images, GPR88-FLAG was labeled with Alexa 488, and the neuronal cilia 
marker Adcy3 was labeled with Alexa 633. For Alexa 488, the detector range was set from 
490–534 nm. For Alexa 633, the detector range was set from 600–750 nm. mCherry was 
detected by direct fluorescence. Images were processed with Fiji. Maximal intensity Z 
projections are from at least 40 slices over 20 μm.
Statistics—Sample sizes were chosen based upon the estimated effect size drawn from 
previous publications7 and from the performed experiments. Data distribution were assumed 
to be normal but this was not formally tested. All test used are indicated in the figures. We 
analyzed all data using Prism 7.0 (GraphPad Software).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. MC4R localizes to the primary cilia in heterologous cells
A) Representative confocal microscopy images of transiently transfected MEF, RPE and 
IMCD3 cells, transfected with MC4R-EGFP labeled for the cilia specific protein acetylated 
Tubulin (TubulinAc, red) and GFP (green), and nuclei with Hoechst 33342 (blue). MC4R-
GFP localize to the primary cilium (yellow arrowheads). Scale bars represent 10 μm. (B) 
Relative ciliary enrichment of melanocortin receptor family members compared to ciliary 
enrichment of GFP (negative control) and Smoothen (postive control). Data are Mean±sem. 
Means were compared to GFP (n=12 cells, mean=1.24) and Dunnet’s multiple comparison 
test was applied. Smo-Myc: n=7 cells, mean= 2.35, p=0,0001; MC1RGFP: n=13 cells, 
mean=1.29, p=0.9995, MC2RGFGP: n=13 cells, mean=1.23, p=0.9999, MC3RGFP: n=10 
cells, mean=1.24, p=0.014; MC4RGFP: n=9 cells, mean=2.68, p=0.0001, MC5RGFP: n=9 
cells, mean=1.96, p=0.0008.
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Figure 2. MC4R localizes specifically to the primary cilia of a subset of PVN neurons in vivo
A) Strategy used to target the mouse Mc4r locus by Crispr/Cas9. B) Schematic 
representation of hypothalamic region studied in C–I. C) Coronal section of the PVN of the 
hypothalamus of a heterozygous MC4R-GFP mouse immunostained for GFP and Adcy3. 
Note that no immunofluorescence is detectable at this resolution. D–I) Maximal intensity 
projections of confocal sections through two PVN regions indicated in C reveals MC4R-
GFP (green) co-localized with neuronal primary cilia (Adcy3, red) in a subset of PVN 
neurons. Co-localization of MC4R-GFP with cilia has been observed in the PVN of over 10 
mice (male and female) derived from two independent founders. Red scale bars represent 
200 μm, White scale bars represent 10 μm.
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Figure 3. A subset of human obesity-associated mutations selectively impair ciliary localization 
of MC4R
A) Relative ciliary enrichment of eight obesity-associated mutant MC4R compared to the 
wild-type (WT) receptor. Data are Mean±sem. Means were compared to MC4RWT (n=16 
cells, mean=2.89) and Dunnet’s multiple comparison test was applied. MC4RR7H: n=10 
cells, mean= 2.57, p=0.28; MC4RT150I: n=17 cells, mean=2.57, p=0.21; MC4RP230L: 
n=12, mean=1.87, p=0.0004, MC4RG231S: n=18, mean=3.10, p=0.39, MC4RR236C: n=22, 
mean=2.1, p=0.0013, MC4RL250Q: n=10, mean=2.83, p=0.85; MC4RG252S: n=11, 
mean=2.72, p=0.54; MC4RI301T: n=4, mean=2.59, p=0.47. B) Design of DIO AAV 
expressing MC4RGFP and MC4RP230LGFP. C) Experimental protocol D) Schematic 
representation of injection site. E, I) Coronal section of the PVN of the hypothalamus of 
Sim1 cre mice injected with the MC4RGFP DIO AAV (E) and the MC4RP230LGFP 
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DIOAAV (I) respectively. (F–H and J–L) Maximal intensity confocal projection of sections 
through the PVN regions indicated in E and I respectively reveals co-localization of 
MC4RGFP (F–H) but not MC4RP230LGFP (J–L) with neuronal primary cilia in PVN 
neurons. Expressions of MC4R-GFP (WT vs P230L) have been observed in the PVN of over 
6 mice (male and female). Red scale bars represent 200 μm, White scale bars represent 10 
μm.
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Figure 4. inhibition of Adenylyl cyclase at the primary cilia of Sim1 PNV neurons is sufficient to 
cause weight gain
A) Experimental protocol (See also supplementary Figure 3). B) Midline stereotaxic 
injections of AAV DIO Flag-GPR88* + AAV DIO mCherry or AAV DIO mCherry were 
performed in male Sim1 cre mice. C) Coronal section of the PVN of the hypothalamus of a 
Sim1 cre mouse injected with the AAV DIO Flag-GPR88* + AAV DIO mCherry. D–F) 
Maximal intensity projections of confocal sections through the PVN region indicated by a 
red square in C. Arrows indicate cilia expressing GPR88. Scale bars represent 10 μm. G) 
Percent weight changes (mean ± SE) of Sim1cre mice following midline PVN injection of 
AAV DIO GPR88(G283H)+ AAV DIO mCherry (n=12) or AAV DIO mCherry (n=9). Mice 
were paired at baseline by body weights and litters. Repeated measures of two-way ANOVA 
followed by Sidak’s multiple comparisons test were performed (treatment F(1, 19) = 8.898, 
P = 0.0076; time F(5, 95) = 49.07, P < 0.0001; interaction F(5,95) = 8.789, P < 0.0001; p 
values from Sidak’s multiple comparisons test are shown in the figure). H) Individual weight 
changes of Sim1cre mice in G) (each line represents one mouse). I) Food intake at baseline 
and 6 weeks after AAV injections (mean± SD). Repeated measures of two-way ANOVA 
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followed by Sidak’s multiple comparisons test were performed (treatment F(1, 19) = 2.41, P 
= 0.1370; time F(1, 19) = 9.328, P = 0.0065; interaction F(1, 19) = 9.196, P = 0.0068; p 
values from Sidak’s multiple comparisons test are shown in the figure). Red scale bars 
represent 200 μm, White scale bars represent 10 μm.
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